凝块制备的差异决定了重组组织型纤溶酶原激活剂治疗实验性血栓栓塞性中风的效果。

Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.

作者信息

Niessen Frank, Hilger Thomas, Hoehn Mathias, Hossmann Konstantin-A

机构信息

Department of Experimental Neurology, Max-Planck-Institute for Neurological Research, Gleueler Strasse 50, D-50931 Cologne, Germany.

出版信息

Stroke. 2003 Aug;34(8):2019-24. doi: 10.1161/01.STR.0000080941.73934.30. Epub 2003 Jul 3.

Abstract

BACKGROUND AND PURPOSE

Thrombin-induced clots used in experimental thromboembolic stroke differ from clots forming spontaneously under clinical conditions. We investigated whether this difference influences the efficacy and outcome of thrombolytic treatment.

METHODS

In rats, the middle cerebral artery was occluded by intracarotid injection of fibrin-rich clots, prepared either according to established methods by adding thrombin to freshly drawn arterial blood or by spontaneous coagulation. The mechanical properties of clots were determined in vitro by elasticity and plasticity tests. One hour after embolism, thrombolysis was started by intra-arterial application of recombinant tissue plasminogen activator (rtPA) (10 mg/kg). Treatment efficacy was monitored by MR measurements of blood perfusion, apparent diffusion coefficient (ADC), T2 relaxation time and blood-brain barrier permeability, and by pictorial measurements of ATP and pH.

RESULTS

Thrombin-induced clots were classified as elastic, and spontaneously forming clots were classified as plastic. Middle cerebral artery embolism with thrombin-induced or spontaneously forming clots led to similar reduction of perfusion and ADC, but rtPA treatment efficacy differed greatly. In the spontaneously forming clot group, blood perfusion returned to or above control within 2 hours, ADC and ATP normalized, tissue pH exhibited alkalosis, and T2 and blood-brain barrier permeability did not change. In the thrombin-induced clot group, in contrast, blood reperfusion was delayed, ADC and ATP remained reduced, tissue pH was acidic, and edema developed, as reflected by increased T2 and blood-brain barrier permeability.

CONCLUSIONS

rtPA-induced thrombolysis promotes rapid reperfusion and tissue recovery in animals embolized with spontaneously forming clots but not in those embolized with thrombin-induced clots. This difference is explained by the different mechanical and possibly molecular consequences of clot preparation and must be considered for the interpretation of thrombolysis experiments.

摘要

背景与目的

实验性血栓栓塞性卒中中使用的凝血酶诱导血栓与临床条件下自发形成的血栓不同。我们研究了这种差异是否会影响溶栓治疗的疗效和结果。

方法

在大鼠中,通过颈内动脉注射富含纤维蛋白的血栓来闭塞大脑中动脉,这些血栓要么按照既定方法通过向新鲜抽取的动脉血中添加凝血酶制备,要么通过自发凝血制备。通过弹性和可塑性测试在体外测定血栓的力学性能。栓塞1小时后,通过动脉内应用重组组织型纤溶酶原激活剂(rtPA)(10mg/kg)开始溶栓。通过磁共振测量血液灌注、表观扩散系数(ADC)、T2弛豫时间和血脑屏障通透性,以及通过ATP和pH的图像测量来监测治疗效果。

结果

凝血酶诱导的血栓被归类为弹性血栓,自发形成的血栓被归类为塑性血栓。用凝血酶诱导或自发形成的血栓进行大脑中动脉栓塞导致类似的灌注和ADC降低,但rtPA治疗效果差异很大。在自发形成血栓的组中,血液灌注在2小时内恢复到对照水平或以上,ADC和ATP恢复正常,组织pH表现为碱中毒,T2和血脑屏障通透性没有变化。相比之下,在凝血酶诱导血栓的组中,血液再灌注延迟,ADC和ATP仍然降低,组织pH呈酸性,并且出现水肿,这通过T2和血脑屏障通透性增加得以体现。

结论

rtPA诱导的溶栓促进了用自发形成血栓栓塞的动物的快速再灌注和组织恢复,但在用凝血酶诱导血栓栓塞的动物中则不然。这种差异可以通过血栓制备的不同力学和可能的分子后果来解释,并且在解释溶栓实验时必须予以考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索